Regeneron Stock Plunges 7.51% Amid Market Sell-Off

On April 29, 2025, Regeneron's stock experienced a significant drop of 7.51% in pre-market trading, reflecting a notable decline in investor sentiment.

Regeneron Pharmaceuticals has been facing a market sell-off, with its stock price declining by 17% and 36% this year. This trend has led to a buy-and-hold strategy being recommended for investors, indicating a potential long-term value in the stock despite short-term volatility.

Regeneron's stock price has been under scrutiny, with recent news highlighting the company's performance and market position. The decision by Mr. Malley to resign from the company was not due to any operational disagreements, suggesting stability in the company's management and strategic direction.